1. Home
  2. AIZ vs BBIO Comparison

AIZ vs BBIO Comparison

Compare AIZ & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assurant Inc.

AIZ

Assurant Inc.

N/A

Current Price

$292.25

Market Cap

13.9B

Sector

Finance

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

N/A

Current Price

$74.72

Market Cap

13.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIZ
BBIO
Founded
1892
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
13.3B
IPO Year
2003
2019

Fundamental Metrics

Financial Performance
Metric
AIZ
BBIO
Price
$292.25
$74.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
23
Target Price
★ $326.67
$107.81
AVG Volume (30 Days)
310.4K
★ 2.5M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
★ 1.20%
N/A
EPS Growth
★ 17.08
N/A
EPS
★ 11.34
N/A
Revenue
★ $12,814,300,000.00
$502,076,000.00
Revenue This Year
$8.31
$107.07
Revenue Next Year
$5.33
$60.44
P/E Ratio
$25.74
★ N/A
Revenue Growth
7.89
★ 126.26
52 Week Low
$207.78
$60.23
52 Week High
$303.94
$93.42

Technical Indicators

Market Signals
Indicator
AIZ
BBIO
Relative Strength Index (RSI) 64.66 69.09
Support Level $271.96 $63.16
Resistance Level $303.94 $75.91
Average True Range (ATR) 4.34 2.18
MACD 1.55 1.02
Stochastic Oscillator 80.76 88.76

Price Performance

Historical Comparison
AIZ
BBIO

About AIZ Assurant Inc.

Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions, consumer electronics and appliances services, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. In addition, the Company reports the Corporate and Other segment, which includes corporate employee-related expenses, activities of the holding company and investments in the home warranty business.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: